What do we know about the drug industry’s agenda to quiet the drumbeat of cost control and transparency proposals? How will the industry target its efforts? Will the battles take place at the state level?  KHN senior correspondent Jay Hancock discussed these issues on Facebook Live Wednesday.

For more in-depth conversations with KHN reporters, check out our Facebook video archive.



from Kaiser Health News http://ift.tt/2AP4Lmq

Related Posts:

0 comments:

Post a Comment

Popular Posts